Lilly's Tirzepatide Shows Promising Results in MASH Resolution and Fibrosis Improvement
Jun 9, 2024
Lilly Equities
Investors Focused on Lilly's Obesity Drugs Success Amid Varied Earnings Reports
Feb 6, 2024
Jim Cramer Considers Eli Lilly a Contender for the 'Magnificent Seven' Mega-Caps
Jan 23, 2024